A comparative study of two estrogen dosages in combined oral contraceptives among Sudanese women.
A prospective study of two combined oral contraceptives was conducted in the Sudan. No pregnancies occurred. Overall incidence of side effects was low. Headache was most frequently reported. Elevations were observed for weight, systolic and diastolic blood pressures, and SGOT and SGPT values while a decrease was seen for hemoglobin levels. Menstrual irregularities were not a problem for the users. Total 6-month use discontinuation rates were low for both pill groups.
D003276:Contraceptives, Oral / Q000633:toxicity*; D003277:Contraceptives, Oral, Combined / Q000633:toxicity; D003278:Contraceptives, Oral, Hormonal / Q000633:toxicity*; D003280:Contraceptives, Oral, Synthetic / Q000633:toxicity; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000633:toxicity*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008111:Liver Function Tests; D008598:Menstruation / Q000187:drug effects; D009644:Norgestrel / Q000008:administration & dosage / Q000633:toxicity*; D011446:Prospective Studies; D011897:Random Allocation; D012959:Socioeconomic Factors; D013397:Sudan
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination